| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/29/1994 | US5298135 Production of electrophoretically-homogenous protein-colloidal gold complexes |
| 03/29/1994 | CA1328147C Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy |
| 03/29/1994 | CA1328070C Purification process of bordetella bacteria protein antigens in order to obtain an acellular vaccine |
| 03/26/1994 | CA2106629A1 Modified platelet factor-4 |
| 03/25/1994 | CA2106821A1 Glycosylated cytokines |
| 03/23/1994 | EP0588754A1 Application of peptide/cell receptor kinetics utilizing radiolabelled somatostatin congeners in the IN SITU, IN VIVO detection and differentiation of neoplastic tissue |
| 03/23/1994 | EP0588750A2 Method for the production of recombinant polypeptides bearing epitopes from different hiv isolates, and their uses as immunogens and in the detection of antibodies against hiv |
| 03/23/1994 | EP0588642A1 Kainate-binding, human CNS receptors of the EAA5 family |
| 03/23/1994 | EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
| 03/23/1994 | EP0588122A1 Improved antibodies to plasmodium falciparum |
| 03/23/1994 | EP0588118A2 Bone-related carboxypeptidase-like protein and process for its production |
| 03/23/1994 | EP0588036A2 Composition for isolating apamin receptors, apamin binding protein and uses thereof |
| 03/23/1994 | EP0587873A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
| 03/23/1994 | EP0587806A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 03/23/1994 | EP0587799A1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 03/23/1994 | EP0587798A1 Insecticidal proteins and method for plant protection |
| 03/23/1994 | EP0587788A1 Methods and compositions of genetic stress response systems |
| 03/23/1994 | EP0587777A1 Cea-binding proteins and methods for their isolation and use |
| 03/23/1994 | EP0587775A1 Induction of ctl responses to foreign antigens expressed in mycobacteria |
| 03/23/1994 | EP0587771A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
| 03/23/1994 | EP0587767A1 Hydroxyazido derivatives and related compounds as renin inhibitors |
| 03/23/1994 | EP0587765A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments |
| 03/23/1994 | EP0587763A1 Method and materials for introducing dna into prevotella ruminicola |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587719A1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO) |
| 03/23/1994 | EP0587636A1 Fish vaccine for aeromonas salmonicida infection |
| 03/23/1994 | EP0587610A1 Specifically beta-beta cross-linked hemoglobins and method of preparation |
| 03/23/1994 | EP0587571A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 03/23/1994 | EP0511978B1 Method of purifying recombinant polypeptides |
| 03/23/1994 | EP0464124B1 A peptide, immunogenic composition and vaccine or medicinal preparation; a method of immunising a mammal against lhrh, and a method of improving the meat quality of pigs |
| 03/23/1994 | EP0433360B1 Improvements relating to the production of prodrugs |
| 03/23/1994 | EP0418234B1 NUCLEIC ACID ENCODING TGF-$g(b)3 AND ITS USE |
| 03/23/1994 | CN1084218A Multiple particulate antigen delivery system |
| 03/22/1994 | US5296608 Intermediates for analogs of tyrosine sulfate or tyrosine phosphate containing peptides |
| 03/22/1994 | US5296594 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 03/22/1994 | US5296592 Process for purifying interleukin-1 receptors |
| 03/22/1994 | US5296465 Containing crosslinked hemoglobin in aqueous carrier medium |
| 03/22/1994 | US5296464 Promoting proliferation of useful microorganism by adding bovine lactoferrin to food containing said microorganisms |
| 03/22/1994 | US5296462 Protecting biomembrane or protein from freezing damage in vitro by applying polypeptide |
| 03/22/1994 | US5296383 Human centromere antigen polypeptide |
| 03/22/1994 | US5296382 Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from Plasmodium falciparum |
| 03/22/1994 | US5296368 Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 03/22/1994 | US5296366 Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant DNA and transformed microorgnaisms |
| 03/22/1994 | US5296353 Evaluation and treatment of patients with progessive immunosuppression |
| 03/22/1994 | CA2078716A1 Attaching and effacing protein of enterohemorrhagic e. coli |
| 03/22/1994 | CA1327936C Phospholipase a_ inhibiting compositions and their use |
| 03/18/1994 | CA2106260A1 Human adeno-associated virus integration site dna and uses thereof |
| 03/18/1994 | CA2106224A1 Bcl-1 locus nucleic acid probes and assay methods |
| 03/17/1994 | WO1994015625A1 Factor viii - polymeric conjugates |
| 03/17/1994 | WO1994005813A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 03/17/1994 | WO1994005811A1 CLONING AND EXPRESSION OF βAPP-C100 RECEPTOR |
| 03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | WO1994005800A1 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005799A1 Sodium ion binding proteins |
| 03/17/1994 | WO1994005793A2 Dna sequences involved in soraphen biosynthesis by myxobacteria |
| 03/17/1994 | WO1994005792A1 Self-assembling recombinant papillomavirus capsid proteins |
| 03/17/1994 | WO1994005791A2 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005790A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 03/17/1994 | WO1994005789A1 Glucagon receptors |
| 03/17/1994 | WO1994005788A1 Neurotrophic peptide |
| 03/17/1994 | WO1994005787A1 Glycopeptides, method of obtaining them and biological applications thereof |
| 03/17/1994 | WO1994005786A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
| 03/17/1994 | WO1994005785A1 Multicistronic expression units and their use |
| 03/17/1994 | WO1994005784A1 Portable intron as an insertion vector for gene insertion |
| 03/17/1994 | WO1994005782A1 In vivo production of transgenic organ by introducing the transgene via lumen |
| 03/17/1994 | WO1994005781A1 Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 03/17/1994 | WO1994005780A1 Fusion glycoproteins |
| 03/17/1994 | WO1994005776A1 Myocyte-specific transcription enhancing factor 2 |
| 03/17/1994 | WO1994005771A2 New bacillus thuringiensis strains and their insecticidal proteins |
| 03/17/1994 | WO1994005703A1 Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis |
| 03/17/1994 | WO1994005702A1 Extraction of collagen |
| 03/17/1994 | WO1994005701A1 Method of preferential labelling of phycobiliprotein with amine-reactive dye for use in a multiple color assay |
| 03/17/1994 | WO1994005700A2 Methods and reagents to detect and characterize norwalk and related viruses |
| 03/17/1994 | WO1994005699A1 Glucagon antagonists and methods for detecting glucagon antagonists |
| 03/17/1994 | WO1994005698A1 Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum |
| 03/17/1994 | WO1994005697A1 Growth hormone potentiating molecules |
| 03/17/1994 | WO1994005696A1 Novel peptide, and antithrombotic agent, anticoagulant for extracorporeal circulation, cell fusion inhibitor, cancer metastasis inhibitor, protective for platelet preparation for transfusion and pack of platelet preparation for transfusion |
| 03/17/1994 | WO1994005695A1 Polypeptides of g-coupled receptor proteins, and compositions and methods thereof |
| 03/17/1994 | WO1994005694A1 Platelet aggregation inhibitors |
| 03/17/1994 | WO1994005692A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 03/17/1994 | WO1994005691A1 Cd27 ligand |
| 03/17/1994 | WO1994005689A1 Cloning and expression of pur protein |
| 03/17/1994 | WO1994005334A1 Vascular in vivo expression of macrophage colony stimulating factor |
| 03/17/1994 | WO1994005333A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | WO1994005328A1 Inhibition of tumor metastasis via neutralization of tissue factor function |
| 03/17/1994 | WO1994005327A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate |
| 03/17/1994 | WO1994005326A1 Novel bacterial vaccines using vaccine strains of pathogenic bacteria |
| 03/17/1994 | WO1994005318A1 Method of treating cell damage or depletion |
| 03/17/1994 | WO1994005316A1 Products and methods for improving keratinocyte adhesion to the dermis |
| 03/17/1994 | WO1994005315A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | WO1994005314A1 Peptide inhibitors of leukocyte adhesion |
| 03/17/1994 | WO1994005311A1 Retro-, inverso-, and retro-inverso synthetic peptide analogues |
| 03/17/1994 | WO1994005310A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | WO1994005308A1 Purification of amphiphilic compounds |
| 03/17/1994 | WO1994005304A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/17/1994 | WO1994005303A1 Peptide diagnostics and therapeutics for spondyloarthropathies |
| 03/17/1994 | WO1994005269A1 Peptide inhibitors of selectin binding |
| 03/17/1994 | WO1994005216A1 Collagen modulators for use in photoablation eximer laser keratectomy |
| 03/17/1994 | WO1994002513A3 Derivatives of eranthis hyemalis lectin |
| 03/17/1994 | WO1994002507A3 Methods for detecting pre-clinical iddm |